Lin BioScience Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	32,470	10,812	8,946	12,583	12,832	6,987
Market Cap Growth	187.76%	20.85%	-28.90%	-1.94%	83.66%	284.89%
Enterprise Value	29,783	8,497	7,788	11,314	11,817	6,797
Last Close Price	392.50	136.58	113.24	170.33	180.59	99.04
PB Ratio	6.07	2.02	2.61	7.25	28.33	7.68
P/TBV Ratio	11.87	3.95	4.41	11.18	28.87	8.60
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.01	0.01
Net Debt / Equity Ratio	-0.97	-0.97	-0.94	-0.92	-1.78	-1.19
Net Debt / EBITDA Ratio	2.63	3.57	2.95	3.61	2.39	5.55
Net Debt / FCF Ratio	4.48	5.05	3.17	4.17	2.76	6.00
Quick Ratio	40.31	33.66	23.70	20.60	1.72	3.56
Current Ratio	41.18	34.45	24.69	20.94	1.74	3.62
Return on Equity (ROE)	-36.34%	-28.66%	-41.08%	-41.98%	-70.57%	-28.85%
Return on Assets (ROA)	-24.81%	-19.97%	-25.16%	-20.05%	-19.74%	-16.78%
Return on Capital Employed (ROCE)	-37.00%	-27.10%	-31.70%	-25.10%	-74.70%	-21.60%
Earnings Yield	-3.15%	-6.88%	-7.68%	-2.49%	-3.39%	-2.17%
FCF Yield	-3.57%	-9.48%	-11.34%	-3.05%	-2.27%	-2.59%
Buyback Yield / Dilution	-3.85%	-6.24%	-3.14%	-4.27%	-10.73%	-4.42%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.